Drug intelligence / Profile preview

GS24-B057

Development stage
Preclinical
Lead developer
Changchun GeneScience Pharmaceutical
Modality
Bispecific Antibodies → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics, Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

**GS24-B057** is a bispecific antibody-drug conjugate (ADC) designed to target both **Nectin-4** and **Trop-2**, two cell surface antigens overexpressed in multiple solid tumors. Developed to enhance clinical efficacy while minimizing toxicity, it features a dual-targeting mechanism with a specified drug-to-antibody ratio (DAR). Preclinical studies position it as a potential best-in-class candidate for treating various solid tumors by delivering cytotoxic payloads selectively to tumor cells expressing these targets.[1][3][5]

02

Targets

TACSTD2 (Tumor-associated calcium signal transducer 2)PVRL4 (Nectin cell adhesion molecule 4)

Beyond the preview

Go deeper on GS24-B057.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GS24-B057.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call